As part of a nationwide clinical trials network for Alzheimer's disease, UC San Diego will help coordinate participating clinical trial sites and standardize how studies are conducted across the network.

A Lehigh University-led research team has received a $2.8 million grant from the National Institutes of Health to develop UniBrain, an AI-enabled platform designed to streamline brain imaging analysis. Led by computer scientist Lifang He, the multi-institutional project aims to simplify complex neuroimaging workflows, expand access to advanced analysis tools, and accelerate research on neurological diseases such as Alzheimer’s and Parkinson’s.

A new international study, led by Lund University, Sweden and Nagoya University, Japan, shows that changes associated with Alzheimer’s disease may affect how rapidly ALS progresses. In time, the findings may contribute to more reliable individual prognoses and better-designed clinical trials. 

Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice.  

A new national initiative at Duke aims to close this gap.  

The Duke Artificial Intelligence and Technology Collaboratory for Aging: Governance and Evaluation (Duke AITC-AIGE) is one of five centers in the National Institute on Aging’s Artificial Intelligence and Technology Collaboratories program selected to receive funding to create a national resource for advancing trustworthy AI in aging and Alzheimer’s disease and related dementias.